Literature DB >> 10446994

Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen.

K David1, M W Ollert, C Vollmert, S Heiligtag, B Eickhoff, R Erttmann, R Bredehorst, C W Vogel.   

Abstract

Sera of healthy humans contain natural cytotoxic IgM antibodies that specifically recognize a Mr 260,000 antigen (NB-p260) on the surface of human neuroblastoma (NB) cells. Here we demonstrate that anti-NB IgM antibodies prepared from different healthy individuals induce, in all human NB cell lines analyzed thus far, typical morphological and biochemical features of apoptosis including nuclear fragmentation, chromatin condensation, and DNA fragmentation. Both the binding of human anti-NB IgM to NB cells and the induction of apoptosis could be inhibited by preincubation of NB cells with murine IgG raised against purified NB-p260. Furthermore, preincubation of human anti-NB IgM with purified NB-p260 immobilized onto a solid support abolished its ability to induce apoptosis in NB cells. Natural human anti-NB IgM failed to bind to and induce apoptosis in control tumor cell lines that lack expression of NB-p260. The anti-NB IgM-induced apoptotic response was also observed in vivo in xenografted human NB tumors. After a single i.v. injection of anti-NB IgM into nude rats bearing solid NB xenografts, many areas of pyknotic cells with fragmented nuclei were observed that stained positive using the terminal dUTP nick end labeling method. In conclusion, the data demonstrate that natural anti-NB IgM antibodies in the sera of healthy individuals are potent mediators of apoptotic cell death of NB cells both in vitro and in vivo. The NB-p260 antigen was identified as the apoptosis-inducing receptor for anti-NB IgM. Whereas natural anti-NB IgM and NB-p260 may be useful tools for immunotherapy of NB, their biological significance remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446994

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

Review 1.  Natural IgM in immune equilibrium and harnessing their therapeutic potential.

Authors:  Srini V Kaveri; Gregg J Silverman; Jagadeesh Bayry
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

2.  IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice.

Authors:  T Vassilev; N Mihaylova; E Voynova; M Nikolova; M Kazatchkine; S Kaveri
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

3.  Day care, childhood infections, and risk of neuroblastoma.

Authors:  Florence Menegaux; Andrew F Olshan; Joseph P Neglia; Brad H Pollock; Melissa L Bondy
Journal:  Am J Epidemiol       Date:  2004-05-01       Impact factor: 4.897

4.  Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma.

Authors:  Shakeel Modak; Brian H Kushner; Kim Kramer; Andrew Vickers; Irene Y Cheung; Nai-Kong V Cheung
Journal:  Oncoimmunology       Date:  2013-03-01       Impact factor: 8.110

5.  In vitro selectivity, in vivo biodistribution and tumour uptake of annexin V radiolabelled with a positron emitting radioisotope.

Authors:  D R Collingridge; M Glaser; S Osman; H Barthel; O C Hutchinson; S K Luthra; F Brady; L Bouchier-Hayes; S J Martin; P Workman; P Price; E O Aboagye
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

6.  Temporal clustering of neuroblastic tumours in children and young adults from Northern England.

Authors:  Colin R Muirhead; Deborah A Tweddle; Nermine O Basta; Richard J Q McNally
Journal:  Environ Health       Date:  2015-09-04       Impact factor: 5.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.